You are here

An Open Label Access Study For Subjects Who Completed A1481156

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
CARE Hospital
Hyderabad, Andhra Pradesh, 500 001 India
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pulmonary Arterial Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
12-30 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects who have completed study A1481156 and are judged by the Investigator to
derive clinical benefit from continuous treatment with sildenafil citrate therapy.

- Subjects with pulmonary arterial hypertension (PAH ) being treated at a study site in
India

- Subjects who are willing and able to comply with scheduled visits, treatment plan, and
other study procedures

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnant or lactating female subjects.

- Current participation in other studies and during study participation, except for the
A1481304 follow-up period.

- Other severe acute or chronic medical or psychiatric condition or laboratory
abnormality that may increase the risk associated with study participation or
investigational product administration and, in the judgment of the investigator, would
make the subject inappropriate for entry into this study.

NCT01582438
Pfizer
No longer available
An Open Label Access Study For Subjects Who Completed A1481156

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Pulmonary Arterial Hypertension
NCT01251848
All Genders
Pulmonary Arterial Hypertension
NCT03364244
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now